Home/ Supplements/ Vitamin K/ D3 5000 IU with Vitamin K2 Apricot Flavo...

D3 5000 IU with Vitamin K2 Apricot Flavor

product on market Tablet or Pill MH Michael's Health Naturopathic Programs Safety: 80/100
80/100

This product is generally safe

  • Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin D3 and K2 are supported by strong evidence for promoting calcium absorption and maintaining bone health. These nutrients work synergistically to regulate calcium deposition in the skeletal system. Research indicates that this combination is generally safe and effective for supporting mineral density.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)

Label

Product Label

Label for D3 5000 IU with Vitamin K2 Apricot Flavor
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Chewable Tablet(s)
Serving Size
90
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

125 mcg (625% DV)
Exceeds UL by 1.2× (UL: 0.1 mg) 608 studies (A:16, B:251)
90 mcg (75% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Xylitol Sorbitol Magnesium Stearate Microcrystalline Cellulose Dicalcium Phosphate Silicon Dioxide Natural Peach Flavor natural Apricot flavor
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: As a dietary supplement, chew one (1) tablet daily. Dosage may be increased as directed by a healthcare practitioner.

Warnings & Precautions

Double-sealed for your protection. Do not use if outer seal is broken or missing.

Caution: Keep out of reach of children.

Not to be taken by pregnant or lactating women

Made in a GMP facility that processes egg, fish, milk, peanut, sesame, shellfish, soy, tree nut and wheat products.

Formulation Notes

Certified Kosher.

Made in the U.S.A.

No added sugar

Additional Information

Shield Star K (Kosher) Parve

Family owned and operated

Metadata

Product Details

UPC / SKU7 55929 10403 1
DSLD Entry Date2023-12-14
Product TypeVitamin
FormTablet or Pill
DSLD ID303376
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.